Making Sense of Bronchoalveolar Lavage Lymphocytosis in Fibrotic Interstitial Lung Disease

por Ryerson, Christopher J.
Publicado 2020

Managing comorbidities in idiopathic pulmonary fibrosis

por Fulton, Blair G, Ryerson, Christopher J
Publicado 2015

Endobronchial Optical Coherence Tomography for the Diagnosis of Fibrotic Interstitial Lung Disease: A Light at the End of the Tunnel?

por Marinescu, Daniel-Costin, Ryerson, Christopher J.
Publicado 2021

The opportunities and challenges of social media in interstitial lung disease: a viewpoint

por Grewal, Japnam S., Kawano-Dourado, Leticia, Ryerson, Christopher J.
Publicado 2021

Progression of fibrosing interstitial lung disease

por Wong, Alyson W., Ryerson, Christopher J., Guler, Sabina A.
Publicado 2020

Reply: Quantitative Computed Tomography in Systemic Sclerosis–Interstitial Lung Disease: Are We Ready to Go beyond Standard Assessment?

por Castillo Saldana, Daniela, Coxson, Harvey O., Ryerson, Christopher J.
Publicado 2021

Pharmacotherapy in pulmonary arterial hypertension: a systematic review and meta-analysis

por Ryerson, Christopher J, Nayar, Shalini, Swiston, John R, Sin, Don D
Publicado 2010

Demographic and clinical predictors of progression and mortality in connective tissue disease-associated interstitial lung disease: a retrospective cohort study

por Chan, Chrystal, Ryerson, Christopher J., Dunne, James V., Wilcox, Pearce G.
Publicado 2019

Cardiopulmonary Exercise Testing in Patients With Interstitial Lung Disease

por Molgat-Seon, Yannick, Schaeffer, Michele R., Ryerson, Christopher J., Guenette, Jordan A.
Publicado 2020

A systematic review on the economic burden of interstitial lung disease and the cost-effectiveness of current therapies

por Wong, Alyson W., Koo, John, Ryerson, Christopher J., Sadatsafavi, Mohsen, Chen, Wenjia
Publicado 2022

Supplemental oxygen and dypsnoea in interstitial lung disease: absence of evidence is not evidence of absence

por Schaeffer, Michele R., Molgat-Seon, Yannick, Ryerson, Christopher J., Guenette, Jordan A.
Publicado 2017

Patient Characteristics and Survival for Progressive Pulmonary Fibrosis Using Different Definitions

por Khor, Yet H., Farooqi, Malik, Hambly, Nathan, Kolb, Martin, Ryerson, Christopher J.
Publicado 2022

Patient-reported outcome measures after COVID-19: a prospective cohort study

por Wong, Alyson W., Shah, Aditi S., Johnston, James C., Carlsten, Christopher, Ryerson, Christopher J.
Publicado 2020

Content Analysis of Idiopathic Pulmonary Fibrosis-related Information on Twitter

por Ong, Shaun, Koo, John, Johannson, Kerri A., Ryerson, Christopher J., Goobie, Gillian C.
Publicado 2022

Systematic review of content and quality of idiopathic pulmonary fibrosis review articles

por Milne, Kathryn M., Chan, Chrystal, Fisher, Jolene H., de Boer, Kaīssa, Ryerson, Christopher J.
Publicado 2018

Frailty and chronic respiratory disease: the need for a multidisciplinary care model

por Symvoulakis, Emmanouil K, Kamekis, Apostolos, Drakonaki, Elena, Mastrodemou, Semeli, Ryerson, Christopher J, Antoniou, Katerina
Publicado 2021

Post-COVID dyspnea: prevalence, predictors, and outcomes in a longitudinal, prospective cohort

por Grewal, Japnam S., Carlsten, Christopher, Johnston, James C., Shah, Aditi S., Wong, Alyson W., Ryerson, Christopher J.
Publicado 2023

Body composition, muscle function, and physical performance in fibrotic interstitial lung disease: a prospective cohort study

por Guler, Sabina A., Hur, Seo Am, Lear, Scott A., Camp, Pat G., Ryerson, Christopher J.
Publicado 2019

Effects of nintedanib in patients with idiopathic pulmonary fibrosis by GAP stage

por Ryerson, Christopher J., Kolb, Martin, Richeldi, Luca, Lee, Joyce, Wachtlin, Daniel, Stowasser, Susanne, Poletti, Venerino
Publicado 2019

Social Media Content of Idiopathic Pulmonary Fibrosis Groups and Pages on Facebook: Cross-sectional Analysis

por Kochan, Andrew, Ong, Shaun, Guler, Sabina, Johannson, Kerri A, Ryerson, Christopher J, Goobie, Gillian C
Publicado 2021